Search Page

1

Cite

Share

The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.

Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F. Wattjes MP, et al. Among authors: richert nd. Mult Scler. 2013 Dec;19(14):1826-40. doi: 10.1177/1352458513510224. Epub 2013 Nov 5. Mult Scler. 2013. PMID: 24192217 Review.

Cite

Share

2

Cite

Share

Does one guideline fit all?

Richert ND, Kryscio RJ. Richert ND, et al. Neurology. 2011 Dec 13;77(24):2080-1. doi: 10.1212/WNL.0b013e31823d76ba. Epub 2011 Nov 16. Neurology. 2011. PMID: 22094478 No abstract available.

Cite

Share

3

Cite

Share

MRI pattern in asymptomatic natalizumab-associated PML.

Wattjes MP, Vennegoor A, Steenwijk MD, de Vos M, Killestein J, van Oosten BW, Mostert J, Siepman DA, Moll W, van Golde AE, Frequin ST, Richert ND, Barkhof F. Wattjes MP, et al. Among authors: richert nd. J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):793-8. doi: 10.1136/jnnp-2014-308630. Epub 2014 Sep 9. J Neurol Neurosurg Psychiatry. 2015. PMID: 25205744

Cite

Share

4

Cite

Share

Magnetization transfer imaging to monitor clinical trials in multiple sclerosis.

Richert ND, Frank JA. Richert ND, et al. Neurology. 1999;53(5 Suppl 3):S29-32. Neurology. 1999. PMID: 10496208 Review.

Cite

Share

5

Cite

Share

Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.

Wattjes MP, Wijburg MT, Vennegoor A, Witte BI, Roosendaal SD, Sanchez E, Liu Y, Martins Jarnalo CO, Richert ND, Uitdehaag BM, Barkhof F, Killestein J. Wattjes MP, et al. Among authors: richert nd. Mult Scler. 2016 Aug;22(9):1174-83. doi: 10.1177/1352458515615225. Epub 2015 Nov 12. Mult Scler. 2016. PMID: 26564995

Cite

Share

6

Cite

Share

Vinculin phosphorylation by the src kinase. Interaction of vinculin with phospholipid vesicles.

Ito S, Werth DK, Richert ND, Pastan I. Ito S, et al. Among authors: richert nd. J Biol Chem. 1983 Dec 10;258(23):14626-31. J Biol Chem. 1983. PMID: 6417142 Free article.

Cite

Share

7

Cite

Share

MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.

Wattjes MP, Wijburg MT, Vennegoor A, Witte BI, de Vos M, Richert ND, Uitdehaag BM, Barkhof F, Killestein J; Dutch-Belgian Natalizumab-associated PML study group. Wattjes MP, et al. Among authors: richert nd. J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):879-84. doi: 10.1136/jnnp-2015-311411. Epub 2015 Sep 14. J Neurol Neurosurg Psychiatry. 2016. PMID: 26369555

Cite

Share

8

Cite

Share

Visualizing the cause of gray matter atrophy in multiple sclerosis.

Richert ND, Kraft E, Stüve O. Richert ND, et al. Arch Neurol. 2009 Feb;66(2):159-60. doi: 10.1001/archneurol.2008.563. Arch Neurol. 2009. PMID: 19204151 No abstract available.

Cite

Share

9

Cite

Share

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

Yousry TA, Pelletier D, Cadavid D, Gass A, Richert ND, Radue EW, Filippi M. Yousry TA, et al. Among authors: richert nd. Ann Neurol. 2012 Nov;72(5):779-87. doi: 10.1002/ana.23676. Ann Neurol. 2012. PMID: 23280794

Cite

Share

10

Cite

Share

Translocator protein PET imaging for glial activation in multiple sclerosis.

Oh U, Fujita M, Ikonomidou VN, Evangelou IE, Matsuura E, Harberts E, Fujimura Y, Richert ND, Ohayon J, Pike VW, Zhang Y, Zoghbi SS, Innis RB, Jacobson S. Oh U, et al. Among authors: richert nd. J Neuroimmune Pharmacol. 2011 Sep;6(3):354-61. doi: 10.1007/s11481-010-9243-6. Epub 2010 Sep 25. J Neuroimmune Pharmacol. 2011. PMID: 20872081 Free PMC article.

Cite

Share